Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG001 in Newly Diagnosed High-Grade Glioma
NCT07609472Phase 2Not yet recruiting
- Sponsor
- FluoGuide
- Start
- Jun 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 2 trial of FG001 in glioma, sponsored by FluoGuide. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
FG001
03
Conditions
glioma
Beyond the preview
Go deeper on NCT07609472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07609472.